About Nanjing Yinhe Biomedical

About company

Nanjing Galaxy Biopharma Co., Ltd (Nanjing Galaxy Biomedical Co., Ltd.) is a brand new subsidiary invested and controlled by Galaxy Bio (stock code: 000806) listed on the Shenzhen Stock Exchange. Development team and professional team leadership management for returning to business experience. The company is committed to the development and application of "humanized" animal platforms, treatment of tumor immunity and autoimmune diseases, screening and optimization of biomacromolecules and the development of innovative drugs and related cutting-edge treatment technologies.